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ABSTRACT
Chromatin-modifying factors play key roles in
transcription, DNA replication and DNA repair. Post-
translational modification of these proteins is largely
responsible for regulating their activity. The FACT
(facilitates chromatin transcription) complex, a
heterodimer of hSpt16 and SSRP1, is a chromatin
structure modulator whose involvement in transcrip-
tion and DNA replication has been reported. Here we
show that nucleosome binding activity of FACT com-
plex is regulated by poly(ADP-ribosyl)ation. hSpt16,
thelargesubunitofFACT,ispoly(ADP-ribosyl)atedby
poly(ADP-ribose) polymerase-1 (PARP-1) resulting
fromphysicalinteractionbetweenthesetwoproteins.
The level of hSpt16 poly(ADP-ribosyl)ation is eleva-
ted after genotoxic treatment and coincides with
the activation of PARP-1. The enhanced hSpt16
poly(ADP-ribosyl)ation level correlates with the
dissociation of FACT from chromatin in response to
DNA damage. Our findings suggest that poly(ADP-
ribosyl)ation of hSpt16 by PARP-1 play regulatory
roles for FACT-mediated chromatin remodeling.
INTRODUCTION
Post-translational modiﬁcation of proteins by phosphory-
lation, acetylation, methylation or poly(ADP-ribosyl)ation
is known to modulate the chromatin-template activities.
Poly(ADP-ribosyl)ationofproteinsmayaffect protein–protein
and protein–DNA interactions (1). In vitro poly(ADP-
ribosyl)ation has been described for many nuclear proteins
that results in a down-regulation of their functions.
Poly(ADP-ribose) polymerases (PARPs) make up a family
of enzymes with conserved catalytic domain at the C-terminal
region (2). These enzymes catalyze the transfer of ADP-ribose
from NAD
+ onto acceptor proteins, including themselves (2).
The most abundant and best-characterized member of PARP
family is PARP-1. Formation of poly(ADP-ribose) polymers
occurs rapidly after DNA damage and appears to be primarily
due to PARP-1 activation. The sites of poly(ADP-ribose)
accumulations often coincide with DNA damage foci or
actively transcribed gene loci (3,4). Although not absolutely
required for repair, loss of PARP-1 reduces the ability of cells
to deal with DNA damage. Recent studies have established
that poly(ADP-ribosyl)ation involves not only in the regula-
tion of cellular response to genotoxic stress, but also ensures
accurate transmission of genetic information during cell divi-
sion (5). Additionally, studies in recent years suggest the
involvement of poly(ADP-ribosyl)ation of proteins in chro-
matin organization. Many targets of PARP-1 are involved in
establishing chromatin architecture (2). Histones, especially
H1 and H2B, are the major poly(ADP-ribosyl)ated chromatin
proteins (6). Poly(ADP-ribosyl)ation of polynucleosomes
causes relaxation of chromatin structure (7). Genetic studies
in Drosophila also showed that PARP-1 is required for proper
chromatin organization throughout the life cycle (8).
The eukaryotic genome is packaged into chromatin, which
present a constant barrier to transcription and other cellular
processes that require access to DNA. The accessibility to
DNA is modulated by protein complexes that remodel chro-
matin structure. Two main enzyme activities that regulate
chromatin accessibility could be distinguished. One class of
chromatin remodeling complex consists of chromatin modi-
fying complex which modiﬁes the histone tail (9). Another
class, ATP-dependent chromatin remodeling complex, uses
energy of ATP hydrolysis to alter the chromatin structure
(10). A recent report using biochemical approach has identi-
ﬁed a new chromatin remodeling factor, FACT (facilitates
chromatin transcription), that allows RNA polymerase II
(pol II) to proceed along the chromatin template (11).
FACT, a heterodimer of hSpt16 and SSRP1 (12), binds and
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chromatin by pol II (13,14). FACT has been found to be
chromatin-associated, consistent with its roles in modulating
chromatin organization (15,16). Genetic studies in yeast
have also demonstrated that both genes are essential for
cell viability, global transcription and cell cycle progres-
sion (15,17,18).
Both PARP-1 and FACT are involved in the global
regulation of chromatin architecture. Recently, two sets of
experiments strongly indicate that there is functional link
between PARP-1 and FACT. A study of Drosophila polytene
chromosomes showed that FACT is recruited to actively tran-
scribed loci after heat shock (19). The kinetics of FACT move-
ment along the hsp70 gene is similar to that of pol II and
elongation factors Spt5 and Spt6. Another study demonstrated
that Drosophila PARP is required for loosening chromatin
structure and normal induction of Hsp70 after heat-shock
(3). Signiﬁcant amount of poly(ADP-ribose) are observed
on the hsp70 foci. These observations suggest that there is
a possible functional link between poly(ADP-ribosyl)ation
and FACT. We have sought to investigate the possible func-
tional interaction between PARP-1 and FACT. We analyzed
the modiﬁcation of FACT immunoprecipitated from human
cells. Our results showed that hSpt16 but not SSRP1 is
poly(ADP-ribosyl)ated in vivo especially following genotoxic
stress. Additionally, we showed that there is a direct inter-
action between hSpt16 and PARP-1. In vitro poly(ADP-
ribosyl)ation assay demonstrated that hSpt16 is a substrate
of PARP-1. We also showed that the nucleosome-binding
activity of hSpt16 and FACT is decreased after poly(ADP-
ribosyl)ation. These results suggest that transcription, DNA
replication or repair may be regulated through the modulation
of chromatin-binding property of FACT by PARP-1.
MATERIALS AND METHODS
Cell culture, plasmids and transient transfection
HeLa and 293T cells were cultured in DMEM supplemented
with 10% fetal bovine serum at 37C in a 5% CO2 atmosphere.
For inhibition of PARP activity, PARP inhibitor 3-
aminobenzamide (3AB) was added to the culture 1 h prior
toirradiationorH2O2treatment.Cellculturesinmid-logphase
of growth were treated with 500 mMH 2O2 for 20 min at 37C
or irradiated in a
137Cs IBL irradiator at room temperature.
Transfection of 293T cells were performed using a standard
calcium-phosphate protocol. The cDNA encoding the full-
length hSpt16, SSRP1 and PARP-1 were cloned into
mammalian expression vector pCMV-Tag2 or recombinant
baculovirus.
Antibodies
The primary antibodies used were as follows: mouse mono-
clonal antibodies anti-FLAG (M2/Sigma), anti-poly(ADP-
ribose) polymer (10H-2/Riken; Japan), anti-tubulin a
(Sigma) and rabbit anti-poly(ADP-ribose) polymer (Roche)
were obtained commercially; monoclonal antibodies anti-
PARP-1 (clone5A5),anti-hSpt16(clone 8D2) andanti-SSRP1
(clone 3E4) and rabbit anti-histone H3 serum were generated
by our lab (Supplementary Figure S1).
Protein purification
Bulk HeLa cells polynucleosomes were puriﬁed as described
previously (20). Mononucleosomes were then created from
these polynucleosomes by digestion with micrococcal nucle-
ase and further puriﬁed by Sephacryl S-400 gel ﬁltration chro-
matography. DNA of puriﬁed mononucleosome was analyzed
on agarose gel. Recombinant human PARP-1, FLAG-tagged
hSpt16 and His-tagged SSRP1 proteins were expressed in
insect cells (Sf9) by recombinant baculoviruses. PARP-1
was puriﬁed to homogeneity by the procedure of Zahradka
and Ebisuzaki (21). Brieﬂy, insect cells were extracted with
extraction buffer followed by two sequential ammonium sul-
fate precipitations of 30 and 70%. The pellet was suspended in
buffer A (50 mM Tris–HCl, pH 8.0, 0.2 M NaCl, 10 mM
2-mercaptoethanol, 50 mM NaHSO3, 1 mM DTT and 1 mM
EDTA) and desalted by passage through a Sephadex G-50
column. PARP-1 was concentrated by DNA-cellulose chro-
matography. Fractions containing puriﬁed enzyme were
pooled and store at 80C in aliquots. Analysis of the puriﬁed
enzyme by SDS–PAGE revealed a single protein of 110 kDa
by Coomassie blue staining. Recombinant FLAG-hSpt16 and
His-SSRP1 were puriﬁed by standard M2 anti-FLAG agarose
or nickel-NTA afﬁnity chromatography. For puriﬁcation of
FACT heterodimer (14), the mixture of insect cell lysates
containing FLAG-hSpt16 and His-SSRP1 was incubated
with nickel-NTA. The bound proteins were eluted from the
beads and subjected to M2 afﬁnity puriﬁcation. After exten-
sive washing, the FACT heterodimers were eluted by FLAG
peptide. The purities of these proteins were >98%, as judged
by SDS–PAGE and Coomassie brilliant blue staining
(Supplementary Figure S2).
Immunoprecipitation and protein interaction assay
HeLa cells were harvested by centrifugation, washed in
phosphate-buffered saline (PBS) and directly lysed with
lysis buffer (20 mM Tris–HCl, pH 7.5, 150 mM NaCl and
0.1% Triton X-100) containing protease inhibitors [1 mg/ml
leupeptin, 1 mg/ml pepstatin and 1 mM phenylmethlysulfonyl
ﬂuoride (PMSF)]. Antibodies pre-bound to protein G–
Sepharose were incubated with lysates for 1 h at 4C rotating
continuously.Beadswere washedthreetimeswithlysisbuffer,
boiled for 5 min followed by analysis on SDS–PAGE.
For mononucleosome-binding assay, immunoprecipitated
FLAG-hSpt16 was washed twice with binding buffer
(10 mM Tris–HCl, pH 7.5, 100 mM KCl, 1 mM MgCl2
and 1 mM DTT). The precipitates were then resuspended in
100 ml of binding buffer containing 100 ng PARP-1 plus 1 mg
mononucleosome and incubated at 37C for 10 min. The reac-
tions were startedby adding NAD
+ to500mM andincubatedat
37C for 40 min. Beads were washed three times with binding
buffer, boiled for 5 min followed by analysis by SDS–PAGE.
Binding of mononucleosome was detected by rabbit anti-
histone H3 antibody. Endogenous FACT precipitated from
HeLa cells was washed with lysis buffer containing 0.5 M
NaCl. After poly(ADP-ribosyl)ation, PARP-1, DNA and
NAD
+ were washed away from the modiﬁed FACT using
lysis buffer containing 0.5 M NaCl. The poly(ADP-
ribosyl)ated FACT and control FACT (incubated with
PARP-1 and DNA in the absence of NAD
+) were incubated
with mononucleosomes at4Cfor2h,washed threetimeswith
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analysis. For pull-down assay, puriﬁed recombinant proteins
(FLAG-hSpt16, His-SSRP1 or FACT heterodimer) were
immobilized on M2 beads or nickel-resin and then incubated
with puriﬁed PARP-1 or mononucleosome in lysis buffer.
PARP-1 poly(ADP-ribosyl)ation assay
Puriﬁed recombinant protein (1.5 mg) was incubated with
100 ng PARP-1 plus various activator (0.1 mg DNA, 6 mg
core histone or 1 mg mononucleosome) in reaction buffer
(10 mM Tris–HCl, pH 7.5, 1 mM MgCl2 and 1 mM DTT)
and incubated at 37C for 10 min. The reactions were started
byadding NAD
+ to 500 mM and incubated at 37C for 10 more
minutes. SDS sample buffer was added to stop the reaction.
The samples were boiled and analyzed by SDS–PAGE.
Poly(ADP-ribose) were detected by immunoblot analysis
using 10H-2 (1:1000) or rabbit serum (1:10000). To study
the interaction between automodiﬁed PARP-1 and hSpt16,
recombinant PARP-1 was bound to protein G beads (15 ml)
with 4 mg rabbit anti-PARP-1 antibody and incubated with
0.1 mg DNA and FLAG-hSpt16 in the presence or absence of
500 mM NAD
+ at 37C for 30 min. The unbound proteins were
washed out with binding buffer.
Biochemical fractionation
Biochemical fractionation of HeLa cells was performed as
described previously with some modiﬁcations (22). Brieﬂy,
HeLa cells were harvested and washed with PBS, and resus-
pended in buffer A (10 mM Tris–HCl, pH 7.5, 10 mM NaCl,
1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol, 1 mM DTT,
1 mg/ml leupeptin, 1 mg/ml pepstatin and 1 mM PMSF). Triton
X-100 was added to ﬁnal concentration of 0.1%, and the cells
were incubated for 5 min on ice. Nuclei were washed once
in buffer A, and then extracted sequentially with increasing
concentrations of NaCl in buffer A. The ﬁnal pellet was resus-
pended in sample buffer. Because sucrose and glycerol inter-
feres the immunoprecipitation efﬁciency of hSpt16, 2 vol of
buffer A without glycerol and sucrose were added to lysates
before immunoprecipitation.
Chromatin immunoprecipitation assay
HeLa cells were cross-linked with 1% formaldehyde for
10 min at room temperature. The cross-linking reaction was
stopped by adding glycine to a ﬁnal concentration of 0.125 M,
and the incubation was continued for 5 min. Cross-linked cells
were washed with PBS and lysed in 1.5 ml lysis buffer (10 mM
Tris–HCl, pH 7.5, 0.25% Triton X-100, 10 mM EDTA,
0.5 mM EGTA and protease inhibitors) on ice for 5 min.
Cells were centrifuged at 600 g for 5 min at 4C. Nuclei
were washed with wash buffer (10 mM Tris–HCl, pH 7.5,
200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA and protease
inhibitor) and centrifuged again under the same condition.
Nuclear pellet was resuspended in 400 ml sonication buffer
(10 mM Tris–HCl, pH 7.5, 100 mM NaCl, 1 mM EDTA,
0.5 mM EGTA and 1% SDS), sonicated with a MSE soniprep
150 sonicator (eight bursts of 5 s each) on ice, and centrifu-
gation at 10000 g for 10 min. The soluble chromatin was
adjusted to RIPA buffer (10 mM Tris, pH 7.5, 0.3% Triton
X-100, 0.1% SDS, 1 mM EDTA, 1 mM EGTA and 150 mM
NaCl). For immunoprecipitation, chromatin was pre-cleared
with 30 ml of protein A–Sepharose beads and immunoprecipi-
tated with 10 ml protein G beads coupled with antibodies
8D2, 3E4 or rabbit anti-histone H3 antiserum for 2 h at 4C.
Immunoprecipitates were washed three times with wash buffer
A (20 mM Tris–HCl, pH 7.5, 0.5% Triton X-100, 0.1% SDS
and 0.5 N NaCl), once with wash buffer B (20 mM Tris–HCl,
pH 7.5, 0.5% Triton X-100, 0.1% SDS and 0.9 N NaCl) and
once with TE (20 mM Tris–HCl, pH 7.5 and 1 mM EDTA).
Immunocomplexes were eluted twice with 100 ml of elution
buffer (TE with 30 mM NaCl and 1% SDS). The input and
pooled eluates were incubated for 6 h at 65C to reverse the
formaldehyde cross-linkage, followed by dilution with 100 ml
of water containing 0.16 mg/ml of proteinase K and incubated
for 1 h at 50C. DNA was puriﬁed with phenol/chloroform and
a fraction was used as PCR template to detect the presence of
actin gene (25–30 cycles of 45 s melting at 95C, 45 s anneal-
ing at 52C, 45 s extension at 72C) using the primers listed
below: Act-F GCTGTTCCAGGCTCTGTTCC; and Act-R
ATGCTCACACGCCACAACATGC. The PCR products
were resolved in 1.9% agarose gels and visualized by ethidium
bromide staining.
RESULTS
hSpt16 but not SSRP1 is poly(ADP-ribosyl)ated in vivo
To gain insight into the regulation of chromatin organization
by poly(ADP-ribosyl)ation of proteins, we tested whether
FACT heterodimer is poly(ADP-ribosyl)ated in vivo. The
poly(ADP-ribosyl)ation status of endogenous FACT immuno-
precipitated from HeLa cells by hSpt16 speciﬁc antibody was
determined using rabbit anti-poly(ADP-ribose) antibody
(Figure 1A). FACT heterodimer remained intact under this
immunoprecipitation condition, as determined by Coomassie
blue staining (data not shown). A speciﬁc, albeit relatively
weak, poly(ADP-ribose) signal corresponding to hSpt16
was detected in the immunoprecipitated FACT (Figure 1A,
lane 2). The results showed that hSpt16 but not SSRP1 is
poly(ADP-ribosyl)ated in vivo. A similar result was obtained
when anti-SSRP1 monoclonal antibody was used to immuno-
precipitateFACTheterodimer(datanotshownandFigure2B).
To demonstrate the speciﬁcity of hSpt16 poly(ADP-
ribosyl)ation, we examined the effects of a general PARP
inhibitor, 3AB, on the poly(ADP-ribosyl)ation patterns
of FACT. The signal of poly(ADP-ribose) polymers in
the 3AB-treated HeLa cells was signiﬁcantly decreased
(Figure 1A,compare lanes 7and 8) while no obvious cytotoxic
effectswere evident.Theinhibitionofpoly(ADP-ribosyl)ation
of hSpt16 by 3AB suggests that PARP activity is involved
(Figure 1A, compare lanes 2 and 3). To exclude the possibility
that the observed signal of poly(ADP-ribose) is due to asso-
ciated proteins which co-migrate with hSpt16 on SDS–PAGE,
recombinant FLAG-tagged hSpt16 or FLAG-tagged SSRP1
was immunoprecipitated from transfected 293T cells with
anti-FLAG M2-agarose and followed by extensive high salt
(0.8 M NaCl) wash to remove possible associated proteins
(Figure 1B). Western blot analysis using anti-poly (ADP-
ribose) antibody (10H-2) revealed that poly(ADP-ribosyl)ated
hSpt16 could still be seen (Figure 1B, lane 2). The level of
precipitated proteins were shown in Figure 1B (lanes 4–6).
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poly(ADP-ribosyl)ated.
A number of proteins are known to be poly(ADP-
ribosyl)ated during DNA damage response. We investigated
the level of poly(ADP-ribosyl)ation of hSpt16 when cells
are exposed to genotoxic stress. As shown in Figure 2A
(lanes 5 and 6), the level of poly(ADP-ribosyl)ation of
immunoprecipitated hSpt16 increased signiﬁcantly after expo-
sure of the cells to H2O2. Pre-incubation of the cells with 3AB
decreased the poly(ADP-ribosyl)ated hSpt16 level (Figure 2A,
compares lanes 2–3 and 6–7). We have also analyzed the
poly(ADP-ribosyl)ation of the FACT immunoprecipitated
from the extracts of g-irradiated cells by SSRP1-speciﬁc anti-
body (Figure 2B). The amount of poly(ADP-ribosyl)ated
hSpt16 increased 30 min post-irradiation. The kinetics
of hSpt16 poly(ADP-ribosyl)ation correlates with the
poly(ADP-ribose) synthesis of cell extracts following g-
irradiation (Figure 2B, compare lanes 1–3 and 6–8). 3AB
treatment also abolished the incorporation of poly(ADP-
ribose) into hSpt16 (Figure 2B, lane 9). The same membrane
was re-probed with anti-FACT antibodies to demonstrate
equal loading of proteins (Figure 2B, lanes 10–18). Taken
together, these observations suggest that FACT is
ploy(ADP-ribosyl)ated under genotoxic stress conditions.
These data further show that poly(ADP-ribosyl)ated hSpt16
remains heterodimerized with SSRP1.
Association of FACT with PARP-1
PARP-1 is the most abundant of PARPs in the cell, accounting
for the synthesis of >90% of the poly(ADP-ribose) following
DNA damage. To examine the possible interaction between
FACT and PARP-1, we performed co-immunoprecipitation
experiments by using whole cell extracts from HeLa cells.
Both monoclonal antibodies against hSpt16 and SSRP1
were used to immunoprecipitate FACT heterodimer from
the cell extracts. As shown in Figure 3A, PARP-1 could be
detected in both anti-hSpt16 and anti-SSRP1 but not in control
antibody immunoprecipitates. These results demonstrate that
FACT heterodimer and PARP1 co-exist in a complex.
Figure1.hSpt16ispoly(ADP-ribosyl)atedinvivo.(A)Poly(ADP-ribosyl)ationstatusofendogenousFACT.HeLacellswereculturedintheabsenceorpresenceof5
mM 3AB for 24 h. FACT heterodimer was immunoprecipitated from lysates and the status of poly(ADP-ribosyl)ation was determined using rabbit anti-
poly(ADP-ribose)antibody(lanes1–3).Thesameblotwasprobedsequentiallywithanti-FACTantibody(8D2and3E4,lanes4–6).Thelevelsofpoly(ADP-ribose)
(pADPr) of cell extracts were shown (lanes 7 and 8). The protein levels of hSpt16 and SSRP1 in lysates were also shown (lower panel, lanes 7 and 8).
(B) FLAG-hSpt16 but not FLAG-SSRP1 is poly(ADP-ribosyl)ated in vivo. Whole cell extracts from 293T cells overexpressing FLAG-hSpt16 or FLAG-SSRP1
were immunoprecipitated with anti-FLAG M2 agarose followed by immunoblotting with monoclonal anti-poly(ADP-ribose) antibody (10H-2) (lanes 1–3). The
same blot was reprobed with anti-FLAG antibody (lanes 4–6). The asterisk indicates bands that were recognized by 10H-2 antibody non-specifically.
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FACT and PARP-1 by performing in vitro pull-down assay
using puriﬁed recombinant proteins. Puriﬁed PARP-1 could
be co-precipitated by recombinant hSpt16 or FACT
heterodimer, while the binding to M2 gel control, Ni-resin
control or His-SSRP1 was close to background level
(Figure 3B). Taken together, these data show that PARP-1
associates with FACT through direct physical interaction
with hSpt16. In vitro pull-down assay using serial deletion
mutants of hSpt16 showed that the central region of hSpt16
is responsible for its interaction with PARP-1 (Supplementary
Figure S3).
hSpt16 is poly(ADP-ribosyl)ated by PARP-1 in vitro
To test the poly(ADP-ribosyl)ation of hSpt16 by PARP-1, we
performed in vitro poly(ADP-ribosyl)ation assays using puri-
ﬁedrecombinantproteins.Poly(ADP-ribosyl)ation dependson
the presence of NAD
+ (Figure 4A, upper panel, lanes 1–4). In
the presence of NAD
+, the slowly migrating smearing bands
detected by the poly(ADP-ribose) antibody are the result of
auto-poly(ADP-ribosyl)ation of PARP-1 (Figure 4A, upper
panel, lane 5). When either FLAG-hSpt16 or FACT het-
erodimer was included in the reaction, an additional band
of poly(ADP-ribose) was observed (Figure 4A, lanes 7 and
8, shown as asterisk on the right side of upper panel). This
band corresponds to the position of FLAG-hSpt16 (Figure 4A,
lower panel, arrowhead) suggesting that the observed signal is
due to poly(ADP-ribosyl)ation of FLAG-hSpt16. No signal of
poly(ADP-ribose) was observed in association with SSRP1
even in the presence of hSpt16 (Figure 4A, upper panel,
lanes 6 and 8). Therefore, these results suggest that hSpt16
but not SSRP1 is a substrate of PARP-1.
Having demonstrated the poly(ADP-ribosyl)ation of
hSpt16 by PARP-1, we then addressed the effect of
poly(ADP-ribosyl)ation on the interaction between hSpt16
and PARP-1. In vitro poly(ADP-ribosyl)ation assays were
carried out using solid-phase PARP-1 (prebound to protein
G beads with PARP-1 speciﬁc antibody) and puriﬁed
FLAG-hSpt16. The interaction between hSpt16 and PARP-1
before or after PARP-1 automodiﬁcation was compared. As
shown in Figure 4B, slow migrating PARP-1 was present on
top portion of the gel, suggesting that PARP-1 was heavily
automodiﬁed, while the level of hSpt16 remained in the
immunoprecipitate was reduced. These results suggest that
like many other PARP-1 substrates, hSpt16 does not interact
with the automodiﬁed PARP-1.
Poly(ADP-ribosyl)ation of hSpt16 alters the
nucleosome binding property of FACT
Previous studies demonstrated that FACT interacts with
mononucleosome via hSpt16 subunit (14). To investigate
the binding of poly(ADP-ribosyl)ated hSpt16 to nucleosomes,
Figure 2. Enhancedpoly(ADP-ribosyl)ationofhSpt16inresponsetoDNAdamage.(A)HeLacellsweremockexposedorexposedto500mMH 2O2inthepresence
orabsenceofPARPinhibitor3ABasindicated.FACTimmunoprecipitatedfromextractsderivedfromequalcellnumbersbyanti-hSpt16antibodywereanalyzedby
immunoblot analysis. Same blot was probed sequentially with rabbit anti-poly(ADP-ribose) antibody (lanes 1–7) and anti-FACT antibodies (8D2 and 3E4,
lanes 8–14). Numbers on the left side indicate positions of protein molecular weight markers. Signals of poly(ADP-ribosyl)ated polypeptides (110 kDa) in
lanes1–3shouldbepoly(ADP-ribosyl)atedPARP-1.(B)HeLacellsweresubjectedtog-irradiation(8Gy)inthepresenceorabsenceofPARPinhibitor3AB.FACT
was immunoprecipitated with anti-SSRP1 antibody (3E4) from lysates prepared before or after irradiation at indicated time and the immunoprecipitates were
analyzedbyimmunoblotanalysis.Sameblotwasprobedsequentiallywithanti-poly(ADP-ribose)antibody(lanes1–9)andanti-FACTantibodies(lanes10–18).The
input lanes showed the loading of HeLa extracts from equal cells numbers (lanes 1–4 and 10–13). Numbers on the left side indicate positions of protein molecular
weight markers.
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nucleosomes, recombinant PARP-1 and FLAG-hSpt16.
Mononucleosomes and core histones were puriﬁed from
HeLa cells (Supplementary Figure S2B). We ﬁrst tested
whether mononucleosome could be activated by mononucleo-
some. As shown in Figure 5A, PARP-1 could be activated by
DNA or mononucleosomes but not by core histones. Further-
more, in the presence of mononucleosomes, hSpt16 could be
poly(ADP-ribosyl)ated by PARP-1 (Figure 5B). These data
suggest that mononucleosome could serve as PARP-1 activa-
tor in the following in vitro mononucleosome-binding assay.
FLAG-hSpt16 was incubated with puriﬁed PARP-1 and
mononucleosome in the presence or absence of NAD
+.
After incubation, unbound proteins were removed by washing
and the bound proteins were subjected to immunoblot analysis
(Figure 5C). FLAG-hSpt16 could bind to mononucleosome as
reported previously (Figure 5C, lane 1 and data not shown).
However, reduced binding of mononucleosome to hSpt16 was
observed after poly(ADP-ribosyl)ation reaction (Figure 5C,
compare lanes 1 and 2). The effect of poly(ADP-ribosyl)ation
of hSpt16 on the nucleosome binding of FACT was also
studied. To exclude the possibility that the decreased inter-
action of FACT with mononucleosomes is due to modiﬁcation
of nucleosomal histones, endogenous FACT was puriﬁed from
HeLa cells, and modiﬁed with PARP-1 in the presence of
absence of NAD
+ (as described in Figure 4A). PARP-1 and
DNA were removed from FACT after poly(ADP-ribosyl)ation
of hSpt16. The nucleosome-binding activity of pre-modiﬁed
or control FACT was compared (Figure 5D). Consistent with
earlier results, disruption of interaction of poly(ADP-
ribosyl)ated FACT with mononucleosome could be observed.
These results indicate that PARP-1-dependent poly(ADP-
ribosyl)ation of hSpt16 diminishes FACT’s ability to associate
with nucleosome in vitro.
Release of FACT from chromatin during
DNA damage response
Finally we investigated whether the altered nucleosome
binding of poly(ADP-ribosyl)ated FACT could be observed
in cells. Previous reports demonstrated that most endogenous
FACT is associated with chromatin (15,16). To study the
possible dissociation of FACT from chromatin in response
to DNA damage, we analyzed the chromatin-bound FACT
by extracting the nuclear preparations from control or
H2O2-treated HeLa cells with increasing concentrations
of NaCl. In the absence of DNA damage, the majority of
FACT was associated with chromatin and only insigniﬁcant
amount of FACT was released between 10 and 100 mM NaCl.
The release of hSpt16 and SSRP1 was observed at 200 mM
NaCl indicating that it is chromatin associated (23). However,
following H2O2 treatment, signiﬁcant portions of FACT were
detected in the soluble fraction (i.e. 10–100 mM NaCl)
suggesting that a population of FACT is released from the
chromatin (Figure 6A, compare lanes 1 and 6). These results
suggest that poly(ADP-ribosyl)ated FACT has weaker
chromatin binding ability. We further studied the poly(ADP-
ribosyl)ation status of FACT immunoprecipitated from
different salt extracted fractions. As shown in Figure 6B,
higher level of poly(ADP-ribose) signal was detected in
hSpt16 precipitated from low salt (100 mM NaCl) than
high salt (i.e. 200 mM) fractions. Taken together, these data
suggest that DNA damage-induced poly(ADP-ribosyl)ated
Spt16 is released from the chromatin.
To further conﬁrm these observations, we performed
chromatin immunoprecipitation (ChIP) assays which can
monitor the interaction between protein and chromatin
more directly. We analyzed the binding of FACT and histone
H3 on the coding region of constitutively expressed g-actin
Figure 3. Interaction between FACT and PARP-1. (A) Co-immunoprecipitation of FACT and PARP-1 from HeLa cells extracts. HeLa whole-cell extracts were
immunoprecipitated with control (non-specific), hSpt16 or SSRP1 antibody. The immunoprecipitates were examined for the presence of PARP-1 (middle panel)
or FACT heterodimer (upper and lower panels) by immunoblotting. (B) FACT interacts with PARP-1 via hSpt16. M2-agarose bound FLAG-hSpt16 (left panel) or
Ni-resin bound His-SSRP1 (right panel) was incubated with different set of purified proteins as indicated. After unbound proteins were removed by washing,
the immunoprecipitates were subjected to immunoblot analysis using the indicated antibodies. M2-agarose beads or Ni-resin were used as controls.
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gene showed no signiﬁcant changes under control or
DNA damage conditions. Consistent with the results in
Figure 6A, the level of hSpt16 or SSRP1 associated with
actin gene was greatly reduced after H2O2 treatment. Further-
more, the reduction in actin gene association of hSpt16 was
alleviated by pre-treatment of the cells with 3AB. The binding
of SSRP1 to the actin gene was only partially attenuated by
pre-treatment of the cells with 3AB. These results further
support the concept that poly(ADP-ribosyl)ation modulates
the nucleosome binding activity of FACT.
DISCUSSION
In this report we demonstrated that hSpt16 is poly(ADP-
ribosyl)ated by PARP-1. We also discovered that this
modiﬁcation is up-regulated in response to genotoxic stress.
These results suggest that the biological functions of FACT
may be regulated by poly(ADP-ribosyl)ation. This ﬁnding
lends further support for the importance of PARP-1-mediated
poly(ADP-ribosyl)ation of chromatin modulators in the
regulation of DNA-dependent processes (24).
Under normal conditions, basal level of poly(ADP-
ribosyl)ated proteins detected in the cells suggest that they
participate not only in cellular response to DNA damage,
but are also involved in the homeostasis of cellular functions.
Previous studies have demonstrated that PARP-1 could be
activated under normal conditions by certain undamaged
DNA structures (25), polynucleosomes (26) and PARP-1
interacting proteins (27). Enzymatic involvement of
PARP-1 in the regulation of pol II dependent transcription
has been reported (28). In a number of model organisms,
PARP-1 has been implicated in regulating gene expression.
For example, activation of PARP-1 has been observed during
transcription activation of genes in Drosophila salivary gland
chromosome (3). Recent studies with PARP-1 null mice and
PARP-1 inhibitors have also demonstrated that the activity of
PARP-1 is essential for NF-kB-dependent gene expression
induced by various inﬂammatory stimuli (29). Poly(ADP-
ribosyl)ation is also known to induce local chromatin
re-organization (28). The nucleosome-binding activity of
hSpt16 and FACT are altered when poly(ADP-ribosyl)ated
by PARP-1 (Figure 5). Our data indicate that PARP-1 may
regulate FACT activity in the pol II dependent transcription.
Belotserkovskaya et al. (14) showed that FACT helps to
remove histones H2B/H2A dimer from a nucleosome during
polIItranscription.TheirmodelsuggeststhatFACTfacilitates
pol II transcription by altering nucleosome structure in front
of pol II and then reestablish chromatin architecture after
Figure 4. In vitro poly(ADP-ribosyl)ation of hSpt16 by PARP-1. (A) hSpt16 is an in vitro substrate of PARP-1. In vitro poly(ADP-ribosyl)ation reactions were
performedusingtheindicatedsetsofrecombinantproteins.ProteinswereseparatedonSDS–PAGEfollowedbyimmunoblot.Thesameblotwasprobedsequentially
with monoclonal anti-poly(ADP-ribose) (pADPr) antibody (upper panel) and anti-FACT antibodies (hSpt16: 8D2 and SSRP-1: 3E4, lower panel). The band
indicated by asterisk represent FLAG-hSpt16 that had been poly(ADP-ribosyl)ated. Arrows indicate the position of SSRP-1. PARP-1 was activated by adding
fragmented DNA and NAD
+.( B) Poly(ADP-ribosyl)ation disrupts the interaction between hSpt16 and PARP-1. In vitro poly(ADP-ribosyl)ation was carried out as
described in (A). PARP-1 was precipitated by rabbit antiserum and the immunoprecipitates were subjected to immunoblot analysis as indicated.
2404 Nucleic Acids Research, 2006, Vol. 34, No. 8pol II pass. But how FACT is switched off and on in vivo
remains a mystery. Although the detailed interaction between
FACT and nucleosome is still unclear, there is a strong pref-
erence for hSpt16 to bind to H2B/H2A dimer (14). Whether
poly(ADP-ribosyl)ated FACT dissociate from nucleosome
through the disruption of its interaction with the histones
remains to be determined.
Transcriptional arrest in response to DNA damage may be
regulated by several mechanisms (30). For example, DNA
damage lesion has been shown to block the progression of
elongating RNA polymerase and the stalled pol II can be
released from the DNA template (30–32). A recent study
found that arrested pol II elongation complexes in response
to DNA damage are the preferred substrates for ubiquityla-
tion (33). This DNA damage-induced polyubiquitylation of
pol II is believed to induce destruction of irreversibly stalled
elongation complex, enabling DNA repair and subsequent
rounds of transcription (34). Published results also supported
that poly(ADP-ribosyl)ation acts as a switch between tran-
scription and DNA repair (35). Following DNA damage,
PARP-1 is highly activated leading to rapid and transient
poly(ADP-ribosyl)ation of nuclear proteins and itself (2).
Active PARP-1 has been suggested to silent transcription
through poly(ADP-ribosyl)ation of transcription factors
which interferes with their DNA-binding activity (36,37).
Our results demonstrate that the narrow time frame of
the increased modiﬁcation on hSpt16 coincides with the
activation of PARP-1 under these conditions (Figure 2).
This immediate modiﬁcation correlates with the decreased
afﬁnity of FACT to chromatin (Figure 6). These data suggest
that when activated, PARP-1 may regulate pol II-dependent
transcription through modiﬁcation of the nucleosome binding
subunit of FACT.
There are at least 18 known members of the PARP gene
family (38). In the present study, we do not exclude the possi-
bility that other PARPs may also be able to modify hSpt16.
PARP-2,which shares somecommonpropertieswith PARP-1,
isapossiblecandidate.PARP-2istheonlyotherPARPreported
to mediate poly(ADP-ribose) synthesis in response to DNA
damage. PARP-1 and PARP-2 participate in overlapping
DNA damage response (39). The possible involvement of
PARP-2intheregulationofFACTmaybestudiedinthefuture.
In this report, poly(ADP-ribosyl)ation of SSRP1 was not
observed. The reduced association of SSRP1 with chromatin
was only partially preserved by pre-treatment with 3AB
(Figure 6C). The interaction between hSpt16 and SSRP1
was not signiﬁcantly inﬂuenced by poly(ADP-ribosyl)ation
(Figures 2 and 5D). Although previous in vitro assays using
puriﬁed nucleosome have shown that hSpt16, but not SSRP1,
is responsible for nucleosome binding property of FACT (14),
SSRP1 was known to bind the speciﬁc structures of DNA
(40,41)—a likely scenario for the observed results in
Figure 6C. In agreement with this possibility, the study of
Li et al. (42) demonstrated that phosphorylation of SSRP1
Figure 5. Poly(ADP-ribosyl)ation of hSpt16 reduced its binding to nucleosome. (A) Stimulation of PARP-1 activity by purified HeLa mononucleosomes. Auto
poly(ADP-ribosyl)ation of PARP-1 were performed using DNA, mononucleosome, and core histones activators as indicated. Poly(ADP-ribose) polymers were
detectedbymonoclonalantibody10H-2(upperpanel).Theinputofcorehistoneandmononucleosomewasshownusinganti-H3antibody(lowerpanel).(B)hSpt16
couldbepoly(ADP-ribosyl)atedwhenusingmononucleosometoactivatePARP-1.Invitropoly(ADP-ribosyl)ationwascarriedoutasdescribedinFigure4Aexcept
thatmononucleosome(notDNA)wasusedtoactivatePARP-1.Thesameblotwasprobedsequentiallywithmonoclonalanti-poly(ADP-ribose)antibody(lanes1and
2)andanti-hSpt16antibodies(lanes3and4).(C)M2agaroseboundFLAG-hSpt16wasincubatedwithPARP-1andmononucleosomeinthepresenceorabsenceof
NAD
+.Afterincubationfor30minat37C,unboundproteinswereremovedbywashingandboundproteinsweresubjecttoimmunoblotanalysisusingantibodiesas
indicatedbytheleftsideofeachpanel.(D)EndogenousFACTwasimmobilizedonproteinGbeadsusinganti-hSpt16antibody.FACTwaseitherpre-modifiedornot
by PARP-1 as described in Figure 4A. Mononucleosome binding assay was performed as in (C).
Nucleic Acids Research, 2006, Vol. 34, No. 8 2405by CK2 in response to UV inhibited the DNA-binding activity
of SSRP1 and FACT in vitro. These observations suggest
that FACT is a target of multiple enzymes that conﬁne
transcription of pol II following genotoxic stress. Indeed,
the complex network of signaling pathways leads to various
post-translational modiﬁcations of FACT or sub-population
of FACT may determine its activity. Accordingly,
poly(ADP-ribosyl)ation of FACT by PARP-1 during geno-
toxic stress may be conﬁned to a sub-population of FACT.
Other modiﬁcations of FACT such as phosphorylation–
dephosphorylation and acetylation–deacetylation may act in
conjunction with poly(ADP-ribosyl)ation to modulate its
nucleosome-binding and functions.
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